331 related articles for article (PubMed ID: 30630850)
1. Naïve T-cell Deficits at Diagnosis and after Chemotherapy Impair Cell Therapy Potential in Pediatric Cancers.
Das RK; Vernau L; Grupp SA; Barrett DM
Cancer Discov; 2019 Apr; 9(4):492-499. PubMed ID: 30630850
[TBL] [Abstract][Full Text] [Related]
2. CAR T-cell Therapy: A New Era in Cancer Immunotherapy.
Miliotou AN; Papadopoulou LC
Curr Pharm Biotechnol; 2018; 19(1):5-18. PubMed ID: 29667553
[TBL] [Abstract][Full Text] [Related]
3. Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer.
Gorchakov AA; Kulemzin SV; Kochneva GV; Taranin AV
Eur Urol; 2020 Mar; 77(3):299-308. PubMed ID: 31471138
[TBL] [Abstract][Full Text] [Related]
4. Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Pearson AD; Rossig C; Mackall C; Shah NN; Baruchel A; Reaman G; Ricafort R; Heenen D; Bassan A; Berntgen M; Bird N; Bleickardt E; Bouchkouj N; Bross P; Brownstein C; Cohen SB; de Rojas T; Ehrlich L; Fox E; Gottschalk S; Hanssens L; Hawkins DS; Horak ID; Taylor DH; Johnson C; Karres D; Ligas F; Ludwinski D; Mamonkin M; Marshall L; Masouleh BK; Matloub Y; Maude S; McDonough J; Minard-Colin V; Norga K; Nysom K; Pappo A; Pearce L; Pieters R; Pule M; Quintás-Cardama A; Richardson N; Schüßler-Lenz M; Scobie N; Sersch MA; Smith MA; Sterba J; Tasian SK; Weigel B; Weiner SL; Zwaan CM; Lesa G; Vassal G
Eur J Cancer; 2022 Jan; 160():112-133. PubMed ID: 34840026
[TBL] [Abstract][Full Text] [Related]
5. Driving CARs on the Highway to Solid Cancer: Some Considerations on the Adoptive Therapy with CAR T Cells.
Abken H
Hum Gene Ther; 2017 Nov; 28(11):1047-1060. PubMed ID: 28810803
[TBL] [Abstract][Full Text] [Related]
6. Lingering effects of chemotherapy on mature T cells impair proliferation.
Das RK; O'Connor RS; Grupp SA; Barrett DM
Blood Adv; 2020 Oct; 4(19):4653-4664. PubMed ID: 33002133
[TBL] [Abstract][Full Text] [Related]
7. Adoptive Cell Therapy in Treating Pediatric Solid Tumors.
Tesfaye M; Savoldo B
Curr Oncol Rep; 2018 Aug; 20(9):73. PubMed ID: 30069644
[TBL] [Abstract][Full Text] [Related]
8. Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell Therapy.
Chen GM; Chen C; Das RK; Gao P; Chen CH; Bandyopadhyay S; Ding YY; Uzun Y; Yu W; Zhu Q; Myers RM; Grupp SA; Barrett DM; Tan K
Cancer Discov; 2021 Sep; 11(9):2186-2199. PubMed ID: 33820778
[TBL] [Abstract][Full Text] [Related]
9. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.
Lee DW; Kochenderfer JN; Stetler-Stevenson M; Cui YK; Delbrook C; Feldman SA; Fry TJ; Orentas R; Sabatino M; Shah NN; Steinberg SM; Stroncek D; Tschernia N; Yuan C; Zhang H; Zhang L; Rosenberg SA; Wayne AS; Mackall CL
Lancet; 2015 Feb; 385(9967):517-528. PubMed ID: 25319501
[TBL] [Abstract][Full Text] [Related]
10. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
[TBL] [Abstract][Full Text] [Related]
11. Wishing on a CAR: Understanding the Scope of Intrinsic T-cell Deficits in Patients with Cancer.
Leick M; Maus MV
Cancer Discov; 2019 Apr; 9(4):466-468. PubMed ID: 30936218
[TBL] [Abstract][Full Text] [Related]
12. Early-phenotype CAR-T cells for the treatment of pediatric cancers.
Meyran D; Terry RL; Zhu JJ; Haber M; Ziegler DS; Ekert PG; Trapani JA; Darcy PK; Neeson PJ
Ann Oncol; 2021 Nov; 32(11):1366-1380. PubMed ID: 34375680
[TBL] [Abstract][Full Text] [Related]
13. Combining chemotherapy with CAR-T cell therapy in treating solid tumors.
Wang AX; Ong XJ; D'Souza C; Neeson PJ; Zhu JJ
Front Immunol; 2023; 14():1140541. PubMed ID: 36949946
[TBL] [Abstract][Full Text] [Related]
14. CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing.
Andersch L; Radke J; Klaus A; Schwiebert S; Winkler A; Schumann E; Grunewald L; Zirngibl F; Flemmig C; Jensen MC; Rossig C; Joussen A; Henssen A; Eggert A; Schulte JH; Künkele A
BMC Cancer; 2019 Sep; 19(1):895. PubMed ID: 31500597
[TBL] [Abstract][Full Text] [Related]
15. Cellular therapy for the treatment of solid tumors.
Grimes JM; Carvajal RD; Muranski P
Transfus Apher Sci; 2021 Feb; 60(1):103056. PubMed ID: 33478888
[TBL] [Abstract][Full Text] [Related]
16. T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T Cells.
Lapteva N; Gilbert M; Diaconu I; Rollins LA; Al-Sabbagh M; Naik S; Krance RA; Tripic T; Hiregange M; Raghavan D; Dakhova O; Rouce RH; Liu H; Omer B; Savoldo B; Dotti G; Cruz CR; Sharpe K; Gates M; Orozco A; Durett A; Pacheco E; Gee AP; Ramos CA; Heslop HE; Brenner MK; Rooney CM
Clin Cancer Res; 2019 Dec; 25(24):7340-7350. PubMed ID: 31558475
[TBL] [Abstract][Full Text] [Related]
17. Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma.
Morgan RA; Johnson LA; Davis JL; Zheng Z; Woolard KD; Reap EA; Feldman SA; Chinnasamy N; Kuan CT; Song H; Zhang W; Fine HA; Rosenberg SA
Hum Gene Ther; 2012 Oct; 23(10):1043-53. PubMed ID: 22780919
[TBL] [Abstract][Full Text] [Related]
18. CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success.
Long KB; Young RM; Boesteanu AC; Davis MM; Melenhorst JJ; Lacey SF; DeGaramo DA; Levine BL; Fraietta JA
Front Immunol; 2018; 9():2740. PubMed ID: 30559740
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of response and resistance to CAR T cell therapies.
Berger TR; Maus MV
Curr Opin Immunol; 2021 Apr; 69():56-64. PubMed ID: 33752101
[TBL] [Abstract][Full Text] [Related]
20. Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells in Humans.
Liu C; Ayyar VS; Zheng X; Chen W; Zheng S; Mody H; Wang W; Heald D; Singh AP; Cao Y
Clin Pharmacol Ther; 2021 Mar; 109(3):716-727. PubMed ID: 33002189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
